The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis

Limin Zhang,1 Yujia Liu,2 Shuai Zhao,1 Zhen Wang,1 Miaomiao Zhang,1 Su Zhang,1 Xinzhuo Wang,1 Shuang Zhang,1 Wenyan Zhang,1 Liying Hao,3 Guangyu Jiao1 1Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, People’s Republic of...

Full description

Bibliographic Details
Main Authors: Zhang L, Liu Y, Zhao S, Wang Z, Zhang M, Zhang S, Wang X, Zhang W, Hao L, Jiao G
Format: Article
Language:English
Published: Dove Medical Press 2022-06-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/the-incidence-and-prevalence-of-pulmonary-hypertension-in-the-copd-pop-peer-reviewed-fulltext-article-COPD
_version_ 1811258248504803328
author Zhang L
Liu Y
Zhao S
Wang Z
Zhang M
Zhang S
Wang X
Zhang S
Zhang W
Hao L
Jiao G
author_facet Zhang L
Liu Y
Zhao S
Wang Z
Zhang M
Zhang S
Wang X
Zhang S
Zhang W
Hao L
Jiao G
author_sort Zhang L
collection DOAJ
description Limin Zhang,1 Yujia Liu,2 Shuai Zhao,1 Zhen Wang,1 Miaomiao Zhang,1 Su Zhang,1 Xinzhuo Wang,1 Shuang Zhang,1 Wenyan Zhang,1 Liying Hao,3 Guangyu Jiao1 1Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, People’s Republic of China; 2College of Traditional Chinese Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, 110032, People’s Republic of China; 3Department of Pharmaceutical Pharmacology and Toxicology, China Medical University, Shenyang, Liaoning, 110000, People’s Republic of ChinaCorrespondence: Guangyu Jiao, Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Sanhao Street, Shenyang, Liaoning, 110004, People’s Republic of China, Tel +8618940251105, Email jiao_gy@163.comPurpose: Chronic obstructive pulmonary disease (COPD)-related pulmonary hypertension (PH) is one of the most common comorbidities of COPD, and often leads to a worse prognosis. Although the estimated prevalence and risk factors of COPD-related PH have been widely reported, these results have not been well integrated. This study aimed to review the worldwide incidence and prevalence of COPD-related PH and explore possible factors affecting its prevalence.Patients and Methods: We searched four electronic databases (Web of Science, Embase, Cochrane, and MEDLINE) to identify all observational studies on the prevalence of COPD-related PH from database creation until July 20, 2021. Eligibility screening, quality assessment, and data extraction of the retrieved studies were independently conducted by two reviewers. Meta-analyses were performed to determine the prevalence of PH in the COPD population. Random-effects meta-regression model analyses were conducted to investigate the sources of heterogeneity.Results: Altogether, 38 articles were included in the meta-analyses. The pooled prevalence was 39.2% (95% CI: 34.0– 44.4, I2 = 97.6%) for COPD-related PH. Subgroup analyses showed that the prevalence of PH increased with COPD severity, where the majority (30.2%) had mild PH and the minority had severe PH (7.2%). Furthermore, we found a significant regional difference in the prevalence of COPD-related PH (P = 0.000), which was the highest in Africa (64.0%) and the lowest in Europe (30.4%). However, stratified studies on other factors involving mean age, sex, enrolment time, participant recruitment settings, and PH diagnostic methods showed no significant differences in prevalence (P > 0.05).Conclusion: The global incidence of PH in the COPD population is very high, and there are significant regional and international variations. Patients with COPD should be screened for PH and contributing risk factors to reduce the burden on individuals and society.Keywords: chronic obstructive pulmonary disease, pulmonary hypertension, prevalence, heterogeneity, meta-analysis
first_indexed 2024-04-12T18:10:22Z
format Article
id doaj.art-b9a42f35e6aa4781b65943b52dbff0e8
institution Directory Open Access Journal
issn 1178-2005
language English
last_indexed 2024-04-12T18:10:22Z
publishDate 2022-06-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-b9a42f35e6aa4781b65943b52dbff0e82022-12-22T03:21:51ZengDove Medical PressInternational Journal of COPD1178-20052022-06-01Volume 171365137975866The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-AnalysisZhang LLiu YZhao SWang ZZhang MZhang SWang XZhang SZhang WHao LJiao GLimin Zhang,1 Yujia Liu,2 Shuai Zhao,1 Zhen Wang,1 Miaomiao Zhang,1 Su Zhang,1 Xinzhuo Wang,1 Shuang Zhang,1 Wenyan Zhang,1 Liying Hao,3 Guangyu Jiao1 1Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, People’s Republic of China; 2College of Traditional Chinese Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, 110032, People’s Republic of China; 3Department of Pharmaceutical Pharmacology and Toxicology, China Medical University, Shenyang, Liaoning, 110000, People’s Republic of ChinaCorrespondence: Guangyu Jiao, Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Sanhao Street, Shenyang, Liaoning, 110004, People’s Republic of China, Tel +8618940251105, Email jiao_gy@163.comPurpose: Chronic obstructive pulmonary disease (COPD)-related pulmonary hypertension (PH) is one of the most common comorbidities of COPD, and often leads to a worse prognosis. Although the estimated prevalence and risk factors of COPD-related PH have been widely reported, these results have not been well integrated. This study aimed to review the worldwide incidence and prevalence of COPD-related PH and explore possible factors affecting its prevalence.Patients and Methods: We searched four electronic databases (Web of Science, Embase, Cochrane, and MEDLINE) to identify all observational studies on the prevalence of COPD-related PH from database creation until July 20, 2021. Eligibility screening, quality assessment, and data extraction of the retrieved studies were independently conducted by two reviewers. Meta-analyses were performed to determine the prevalence of PH in the COPD population. Random-effects meta-regression model analyses were conducted to investigate the sources of heterogeneity.Results: Altogether, 38 articles were included in the meta-analyses. The pooled prevalence was 39.2% (95% CI: 34.0– 44.4, I2 = 97.6%) for COPD-related PH. Subgroup analyses showed that the prevalence of PH increased with COPD severity, where the majority (30.2%) had mild PH and the minority had severe PH (7.2%). Furthermore, we found a significant regional difference in the prevalence of COPD-related PH (P = 0.000), which was the highest in Africa (64.0%) and the lowest in Europe (30.4%). However, stratified studies on other factors involving mean age, sex, enrolment time, participant recruitment settings, and PH diagnostic methods showed no significant differences in prevalence (P > 0.05).Conclusion: The global incidence of PH in the COPD population is very high, and there are significant regional and international variations. Patients with COPD should be screened for PH and contributing risk factors to reduce the burden on individuals and society.Keywords: chronic obstructive pulmonary disease, pulmonary hypertension, prevalence, heterogeneity, meta-analysishttps://www.dovepress.com/the-incidence-and-prevalence-of-pulmonary-hypertension-in-the-copd-pop-peer-reviewed-fulltext-article-COPDchronic obstructive pulmonary diseasepulmonary hypertensionprevalenceheterogeneitymeta-analysis
spellingShingle Zhang L
Liu Y
Zhao S
Wang Z
Zhang M
Zhang S
Wang X
Zhang S
Zhang W
Hao L
Jiao G
The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis
International Journal of COPD
chronic obstructive pulmonary disease
pulmonary hypertension
prevalence
heterogeneity
meta-analysis
title The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis
title_full The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis
title_fullStr The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis
title_full_unstemmed The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis
title_short The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis
title_sort incidence and prevalence of pulmonary hypertension in the copd population a systematic review and meta analysis
topic chronic obstructive pulmonary disease
pulmonary hypertension
prevalence
heterogeneity
meta-analysis
url https://www.dovepress.com/the-incidence-and-prevalence-of-pulmonary-hypertension-in-the-copd-pop-peer-reviewed-fulltext-article-COPD
work_keys_str_mv AT zhangl theincidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT liuy theincidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT zhaos theincidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT wangz theincidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT zhangm theincidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT zhangs theincidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT wangx theincidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT zhangs theincidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT zhangw theincidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT haol theincidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT jiaog theincidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT zhangl incidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT liuy incidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT zhaos incidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT wangz incidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT zhangm incidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT zhangs incidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT wangx incidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT zhangs incidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT zhangw incidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT haol incidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis
AT jiaog incidenceandprevalenceofpulmonaryhypertensioninthecopdpopulationasystematicreviewandmetaanalysis